Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2010
03/18/2010WO2010030716A1 Detection of nucleic acids by oligonucleotide probes cleaved in presence of endonuclease v
03/18/2010WO2010030643A1 Diagnosis and prognosis of immune disorders using stat4 expression
03/18/2010WO2010030608A1 Methods for detecting and quantifying oversulfated glycosaminoglycans
03/18/2010WO2010030604A2 Methods and compositions for determining and monitoring dietary supplementation
03/18/2010WO2010030600A2 Methods and compositions for personalization of dietary supplements based on genetic markers
03/18/2010WO2010030425A1 Open-reading-frame (orf) phage display
03/18/2010WO2010030365A2 Thyroid tumors identified
03/18/2010WO2010030355A2 Targeted chemical high-throughput screening method
03/18/2010WO2010030343A1 Bioluminescent assays using cyanobenzothiazole compounds
03/18/2010WO2010030293A1 Methods, systems, and compositions for cancer diagnosis
03/18/2010WO2010030243A1 Gene sequences for the detection of chikungunya and dengue fever
03/18/2010WO2010030171A1 Method for diagnostic marker development
03/18/2010WO2010030049A1 Composition for detection of m. tuberculosis complex or mycobacteria genus and simultaneous detection method for m. tuberculosis complex and mycobacteria genus with multiplex real time pcr using the same
03/18/2010WO2010030035A1 Impedance spectroscopy measurement of dna
03/18/2010WO2010029629A1 Dna-containing ink composition
03/18/2010WO2010029548A1 Method for identifying genetic loci invovled in hybrid vigor
03/18/2010WO2010029527A1 A method for predicting athletic performance potential
03/18/2010WO2010029520A1 Primer and amplification method for forming single stranded dna amplicons
03/18/2010WO2010029440A1 Molecular classifier for evaluating the risk of metastasic relapse in breast cancer
03/18/2010WO2010029378A2 Anti-protozoa compounds
03/18/2010WO2010029360A1 Compositions and methods for the rapid growth and detection of microorganisms
03/18/2010WO2010029309A1 Analysis of the size of nucleic acids
03/18/2010WO2010029176A1 Genes associated with posttraumatic-stress disorder (ptsd)
03/18/2010WO2010029174A2 Method
03/18/2010WO2010029170A2 Method for the prognosis and diagnosis of type ii diabetes in critical persons
03/18/2010WO2010029167A2 Means and methods for evaluating a therapy with a p38 map kinase inhibitor
03/18/2010WO2010028863A1 Method to eliminate polymerase chain reaction inhibitors from faecal samples
03/18/2010WO2010028443A1 Microrna target identification assay
03/18/2010WO2010010211A3 Disposable amperometric biosensor, production method thereof and method for determining the presence of analytes in foods
03/18/2010WO2010009368A3 Compositions for the detection and treatment of colorectal cancer
03/18/2010WO2010004591A3 Genetic variants for breast cancer risk assessment
03/18/2010WO2010004164A3 Culture medium containing a spore germination inhibiting or delaying compound
03/18/2010WO2009158024A3 Microfluidic droplets for metabolic engineering and other applications
03/18/2010WO2009155103A3 Compositions for use in identification of tick-borne pathogens
03/18/2010WO2009153779A3 Genotyping method and means thereof for use in traceability schemes
03/18/2010WO2009153775A3 Methods for distinguishing between specific types of lung cancers
03/18/2010WO2009148528A8 Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
03/18/2010WO2009146859A3 Methods and compositions in the treatment of coronaviruses
03/18/2010WO2009146460A3 Methods for disease therapy
03/18/2010WO2009146098A3 Stem cells and uses thereof
03/18/2010WO2009138689A3 In vitro detection of antibodies produced following a legionella pneumophila infection
03/18/2010WO2009134322A3 Lysine riboswitch and compositions and uses thereof
03/18/2010WO2009126804A3 Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis
03/18/2010WO2009089831A3 Base-modified primer oligomers for multiplex rt-pcr
03/18/2010WO2009088442A3 Isomerases and epimerases and methods of using
03/18/2010WO2009051672A3 Natural killer immunoglobulin-like receptor (kir) assay
03/18/2010WO2008125365A8 Microbial population analysis
03/18/2010US20100071095 Method for Generating Plant Diversity By Incorporation of Microsatellite Sequences Into the Plant Genome
03/18/2010US20100071091 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
03/18/2010US20100071078 Rspondins as modulators of angiogenesis and vasculogenesis
03/18/2010US20100070530 Nucleotide Sequence Screening
03/18/2010US20100070196 Blood Glucose Tracking Apparatus and Methods
03/18/2010US20100070192 Optimization of crossover points for directed evolution
03/18/2010US20100070191 Lung Cancer Biomarkers and Uses Thereof
03/18/2010US20100070186 Methods of screening for and mapping phenotypic and genotypic variations in cells
03/18/2010US20100070184 Method for determining resistance of hiv to protease inhibitor treatment
03/18/2010US20100069624 Nucleic Acid Mediated Electron Transfer
03/18/2010US20100069611 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target
03/18/2010US20100069470 Identification of protein biomarkers associated with lymph node metastasis in colorectal cancer
03/18/2010US20100069465 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
03/18/2010US20100069464 Compositions and methods for modulating activity of capped small rnas
03/18/2010US20100069463 Methods for the diagnosis and treatment of affective disorders and cushing's syndromes
03/18/2010US20100069462 Mitochondrial function of prohibitin 2 (phb2)
03/18/2010US20100069344 Small molecule antagonists of bcl2 family proteins
03/18/2010US20100069343 Methods of predicting steroid responsiveness with Il-1RII
03/18/2010US20100069334 Diagnostic method
03/18/2010US20100069304 Protective effects of inhibiting the interaction of calmodulin and mutant huntingtin protein
03/18/2010US20100069298 Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same
03/18/2010US20100069258 Hydrophilic Labels for Biomolecules
03/18/2010US20100069255 Method for identifying therapeutical targets in secondary tumors, the use of thereof and means for identifying, labelling and targeting secondary tumors
03/18/2010US20100069254 Cell Culture Model for Demyelination/Remyelination
03/18/2010US20100069251 Methods for producing embryonic stem cells from parthenogenetic embryos
03/18/2010US20100069250 Digital PCR Calibration for High Throughput Sequencing
03/18/2010US20100068803 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof
03/18/2010US20100068796 Blood Glucose Tracking Apparatus and Methods
03/18/2010US20100068756 Method and apparatus for detecting and quantifying bacterial spores on a surface
03/18/2010US20100068755 Method and system for detection and/or characterization of a biological particle in a sample
03/18/2010US20100068754 Density-based cell detection system
03/18/2010US20100068753 Biotin-facilitated transport in gram negative bacteria
03/18/2010US20100068752 Novel fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest
03/18/2010US20100068751 Method and System for Artifact Reduction
03/18/2010US20100068750 Method for fluorometrically determining photosynthesis parameters of photoautotropic organisms, device for carrying out said method and a measurement chamber
03/18/2010US20100068749 Optical sensor and method for indicating the age or quality of a natural product
03/18/2010US20100068748 Fluorescent Ion Indicators for Cadmium and Lanthanide Ion Detection
03/18/2010US20100068747 Generic Assay for Monitoring Endocytosis
03/18/2010US20100068746 Diagnosis method for fatty liver disease, diagnosis apparatus, diagnosis program, diagnostic agent, and method for screening for therapeutic agent for fatty liver disease
03/18/2010US20100068745 Process and kit for measuring the condition of the fibrinolitic system
03/18/2010US20100068744 Method for the purification of heat shock proteins
03/18/2010US20100068743 Method for predicting response of cancer patient to anticancer drug treatment
03/18/2010US20100068742 Methods
03/18/2010US20100068741 Assay system for adenosine triphosphate and creatine kinase
03/18/2010US20100068740 Microfluidic device with a cylindrical microchannel and a method for fabricating same
03/18/2010US20100068739 PH Tolerant Luciferase
03/18/2010US20100068731 Use of N-Myristoyltransferase on Non-Tumor Tissue for Cancer Diagnosis
03/18/2010US20100068730 Method for screening anti-cancer compounds inhibiting function of tm4sf5 and anti-cancer composition containing chalcone compounds
03/18/2010US20100068723 DNA sequencing and genotyping, proteomics, pathogen detection, diagnostics and biodefense; devices for the interfacing of microchips to various types of modules
03/18/2010US20100068722 increase the intensity of the fluorescent signal after nucleic acid sequencing reactions; a modified fluorescent labelled guanine-containing nucleotides which exhibit enhanced fluorophore intensity
03/18/2010US20100068721 Method and system for protection and cross protection of algae and cyanobacteria from virus an bacteriophage infections
03/18/2010US20100068720 Method and kit for detection of early cancer or pre-cancer using blood and body fluids
03/18/2010US20100068719 Cell culture system for determinging the sensitizing, allergenic and/or irritating effect of a substance